About Dante Labs
Dante Labs is a company based in New York (United States) founded in 2016 by Andrea Riposati and Mattia Capulli. Dante Labs has completed 1 acquisition, including Cambridge Cancer Genomics. Dante Labs offers products and services including Dante Genome Test, Genomic Reports, ACMG Report, and Achromatopsia Report. Dante Labs operates in a competitive market with competitors including Defenxa, Flylife, DNA 4Future and DF Medica, among others.
- Headquarter New York, United States
- Founders Andrea Riposati, Mattia Capulli
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Governo Italiano
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dante Labs
Dante Labs offers a comprehensive portfolio of products and services, including Dante Genome Test, Genomic Reports, ACMG Report, and Achromatopsia Report.
Comprehensive sequencing for personalized health and genetic insights
Detailed reports on genetic variants for disease identification
Specialized analysis for genetic conditions and recommendations
Focused genetic evaluation for specific rare disorders
People of Dante Labs
Unlock access to complete
Funding Insights of Dante Labs
Investors in Dante Labs
Dante Labs has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Governo Italiano and iStarter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector agnostic startup accelerator
|
Locked | Locked | Locked | |
|
The Italian Government is administered through the Presidency of the Council of Ministers.
|
Locked | Locked | Locked |
Investor details for Dante Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dante Labs
Dante Labs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cambridge Cancer Genomics.
Investment portfolio details for Dante Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of AI-based precision medicine tools for oncologists
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Dante Labs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Dante Labs
Detailed financials for Dante Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dante Labs Comparisons
Peer comparison for Dante Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dante Labs
Dante Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Defenxa, Flylife, DNA 4Future and DF Medica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides rapid COVID-19 serological tests and health management apps for consumers.
|
|
| Locked | Locked | Locked |
Provides direct-to-consumer genetic testing services for health and wellness.
|
|
| Locked | Locked | Locked |
Offers DNA test kits for personalized management of fitness, diet, and skin health.
|
|
| Locked | Locked | Locked |
Provides DNA-based programs for personalized nutrition, health management, and genetic testing.
|
Detailed competitors of Dante Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dante Labs
Complete news archive for Dante Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dante Labs
Dante Labs was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Dante Labs is headquartered in New York, United States. It is registered at New York, New York, United States.
Andrea Riposati is the current CEO of Dante Labs. They have also founded this company.
Dante Labs was founded in 2016 in New York, United States, within the genomics sector. Whole-genome sequencing services, including mitochondrial DNA, are provided to deliver insights on health risks, hereditary diseases, and longevity. Operations involve online kits for sample collection and digital result delivery. Post-analysis reports cover genetic predispositions, wellness factors, medication responses, rare diseases, and related conditions, supporting informed health decisions.
Dante Labs's top competitors include Defenxa, Flylife and DNA 4Future.
Dante Labs offers Dante Genome Test, Genomic Reports, ACMG Report, and Achromatopsia Report.
Dante Labs has made 1 acquisition, including Cambridge Cancer Genomics.
Dante Labs has 2 investors. Key investors include Governo Italiano, and iStarter.